BPC-157 + TB-500 5mg/5mg (10mg/7ml) Research Spray Kit

Molecular Formula

C98H144N28O32 (BPC-157), C212H350N56O78S (TB-500)

BPC-157 and TB-500 each have unique mechanisms of action that contribute to their combined properties in laboratory research. BPC-157 has been examined for its impact on angiogenesis, collagen synthesis, and modulation of the nitric oxide (NO) system. It has also been shown to affect inflammatory mediators such as cytokines and free radicals.

TB-500 is involved in regulating actin polymerization, a process relevant to cell migration in experimental models. It has also been investigated for its effects on keratinocyte and endothelial cell migration, as well as on inflammatory cytokines.

When analyzed together in laboratory settings, BPC-157 and TB-500 can be used to explore potential synergistic influences on cellular behavior, angiogenesis, collagen production, and inflammatory pathways.

The BPC-157 and TB-500 blend is supplied for laboratory research purposes only. Researchers can use this peptide combination to explore its properties and effects in experimental models. Some areas of study include:

• Cellular behavior in wound models: The combination has been examined for its influence on cell migration, angiogenesis, and collagen synthesis in experimental wound models.
• Tissue regeneration research: This blend may be used to study regenerative processes in various tissue types under laboratory conditions.
• Inflammatory response modulation: Both peptides have been observed to affect cytokine activity and other markers of inflammation in experimental settings.
• Neuroscience research: BPC-157 has been investigated for potential effects on neuronal cells in laboratory studies.
• Vascular studies: Researchers may examine angiogenesis and blood vessel formation in controlled experimental systems.
• Musculoskeletal models: The peptide combination can be applied in research exploring cell migration, tissue remodeling, and other musculoskeletal processes in vitro or in vivo models.

We provide this BPC-157 + TB-500 Blend + Research Spray Kit specifically for research use; scientists and students may utilize it to analyze peptide stability, interactions, and delivery methods under structured research environments. With access to these peptide compounds, researchers will be able to evaluate both individual and blended peptide behaviors. And the spray tool allows for alternative administration routes and bioavailability comparisons. Supplied as a lyophilized, water-soluble powder, the blend requires reconstitution before use and should be handled with standard laboratory safety practices, including proper storage, sterile preparation, and disposal protocols.

1. Chang, C. H., Tsai, W. C., Lin, M. S., Hsu, Y. H., & Pang, J. H. S. (2011). The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. Journal of Applied Physiology, 110(3), 774-780. https://pubmed.ncbi.nlm.nih.gov/21030672/

2. Huang, T., Zhang, K., Sun, L., Xue, X., Zhang, C., Shu, Z., ... & Pang, J. (2015). Body protective compound-157 enhances alkali-burn wound healing in vivo and promotes proliferation, migration, and angiogenesis in vitro. Drug Design, Development and Therapy, 9, 2485. https://pubmed.ncbi.nlm.nih.gov/25995620/

3. Sikiric, P., Seiwerth, S., Rucman, R., Turkovic, B., Rokotov, D. S., Brcic, L., ... & Vlainic, J. (2014). Stable gastric pentadecapeptide BPC 157-NO-system relation. Current Pharmaceutical Design, 20(7), 1126-1135. https://pubmed.ncbi.nlm.nih.gov/23755725/

4. Philp, D., Kleinman, H. K., & Goldblatt, P. J. (2010). Thymosin β4 and the potential for therapeutic applications. Expert Opinion on Biological Therapy, 10(1), 149-158. https://pubmed.ncbi.nlm.nih.gov/20001564/

5. Sosne, G., Qiu, P., Goldstein, A. L., & Wheater, M. (2010). Biological activities of thymosin β4 defined by active sites in short peptide sequences. The FASEB Journal, 24(7), 2144-2151. https://pubmed.ncbi.nlm.nih.gov/20179146/

6. Hsieh, M. J., Liu, H. T., Wang, C. N., Huang, H. Y., Lin, Y., Ko, Y. S., ... & Pang, J. H. S. (2017). Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation. Journal of Molecular Medicine, 95(3), 323-333. https://pubmed.ncbi.nlm.nih.gov/27847966/